Sutro Biopharma Statistics Share Statistics Sutro Biopharma has 84.46M
shares outstanding. The number of shares has increased by 3.05%
in one year.
Shares Outstanding 84.46M Shares Change (YoY) 3.05% Shares Change (QoQ) 0.82% Owned by Institutions (%) 74.22% Shares Floating 78.33M Failed to Deliver (FTD) Shares 40,725 FTD / Avg. Volume 4.6%
Short Selling Information The latest short interest is 3.66M, so 4.33% of the outstanding
shares have been sold short.
Short Interest 3.66M Short % of Shares Out 4.33% Short % of Float 4.36% Short Ratio (days to cover) 7.55
Valuation Ratios The PE ratio is -0.62 and the forward
PE ratio is -0.79.
Sutro Biopharma's PEG ratio is
-0.01.
PE Ratio -0.62 Forward PE -0.79 PS Ratio 2.28 Forward PS 1.3 PB Ratio 3.17 P/FCF Ratio -0.73 PEG Ratio -0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Sutro Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.6,
with a Debt / Equity ratio of 0.52.
Current Ratio 2.6 Quick Ratio 2.6 Debt / Equity 0.52 Debt / EBITDA -0.13 Debt / FCF -0.12 Interest Coverage -7.67
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $230.64K Profits Per Employee $-845.58K Employee Count 269 Asset Turnover 0.16 Inventory Turnover n/a
Taxes Income Tax 2.36M Effective Tax Rate -1.05%
Stock Price Statistics The stock price has increased by -76.23% in the
last 52 weeks. The beta is 1.67, so Sutro Biopharma's
price volatility has been higher than the market average.
Beta 1.67 52-Week Price Change -76.23% 50-Day Moving Average 0.81 200-Day Moving Average 1.56 Relative Strength Index (RSI) 47.7 Average Volume (20 Days) 884,882
Income Statement In the last 12 months, Sutro Biopharma had revenue of 62.04M
and earned -227.46M
in profits. Earnings per share was -2.96.
Revenue 62.04M Gross Profit 54.83M Operating Income -238.45M Net Income -227.46M EBITDA -180.45M EBIT -194.03M Earnings Per Share (EPS) -2.96
Full Income Statement Balance Sheet The company has 190.3M in cash and 23.15M in
debt, giving a net cash position of 167.15M.
Cash & Cash Equivalents 190.3M Total Debt 23.15M Net Cash 167.15M Retained Earnings -786.87M Total Assets 321.43M Working Capital 154.36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -191.54M
and capital expenditures -3.1M, giving a free cash flow of -194.64M.
Operating Cash Flow -191.54M Capital Expenditures -3.1M Free Cash Flow -194.64M FCF Per Share -2.53
Full Cash Flow Statement Margins Gross margin is 88.37%, with operating and profit margins of -384.34% and -366.62%.
Gross Margin 88.37% Operating Margin -384.34% Pretax Margin -362.81% Profit Margin -366.62% EBITDA Margin -290.85% EBIT Margin -384.34% FCF Margin -313.71%
